Daniel L. Reuvers - 11 Mar 2025 Form 4 Insider Report for TACTILE SYSTEMS TECHNOLOGY INC (TCMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Mar 2025, 16:20:47 UTC
Prior SEC filing
27 Feb 2025
Next SEC filing
23 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Zimmerman, Attorney-in-Fact

Key filing fact

Daniel L. Reuvers filed Form 4 for TACTILE SYSTEMS TECHNOLOGY INC (TCMD) on 13 Mar 2025.

Key facts

  • This page summarizes Daniel L. Reuvers's Form 4 filing for TACTILE SYSTEMS TECHNOLOGY INC (TCMD).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Mar 2025, 16:20.

Change

  • Previous filing in this sequence was filed on 27 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TCMD transaction

Common Stock

Gift

Transaction value
$0
Shares
-68,162
Change %
-32%
Price
$0.000000
Shares after
146,442
Date
11 Mar 2025
Ownership
Direct
TCMD transaction

Common Stock

Gift

Transaction value
$0
Shares
+68,162
Change %
Price
$0.000000
Shares after
68,162
Date
11 Mar 2025
Ownership
By Family Trust
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .